https://orcid.org/0000-0002-1023-5597
Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Songdi Zhang, Lijuan Zhang, Aikedai Yusufu, Hadiliya Hasimu, Xiaodong Wang & Paride Abliz. (2024) Clinical Distribution and Drug Susceptibility Characterization of Invasive Candida Isolates in a Tertiary Hospital of Xinjiang Province. Infection and Drug Resistance 17, pages 1345-1356.
Read now
Read now
Alessandra Oliva, Francesco Giuseppe De Rosa, Malgorzata Mikulska, Federico Pea, Maurizio Sanguinetti, Carlo Tascini & Mario Venditti. (2023) Invasive Candida infection: epidemiology, clinical and therapeutic aspects of an evolving disease and the role of rezafungin. Expert Review of Anti-infective Therapy 21:9, pages 957-975.
Read now
Read now
Articles from other publishers (13)
Benjamin A. August & Pramodini B. Kale‐Pradhan. (2024) Management of invasive candidiasis: A focus on rezafungin, ibrexafungerp, and fosmanogepix. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 44:6, pages 467-479.
Crossref
Crossref
Teresa Nascimento, João Inácio, Daniela Guerreiro, Patrícia Patrício, Luís Proença, Cristina Toscano, Priscila Diaz & Helena Barroso. (2024) Insights into Candida Colonization in Intensive Care Unit Patients: A Prospective Multicenter Study. Journal of Fungi 10:6, pages 378.
Crossref
Crossref
Silvia De Gaetano, Angelina Midiri, Giuseppe Mancuso, Maria Giovanna Avola & Carmelo Biondo. (2024) Candida auris Outbreaks: Current Status and Future Perspectives. Microorganisms 12:5, pages 927.
Crossref
Crossref
Namrata Singh, Vibha Kumari, Karan Agrawal & Mayank Kulshreshtha. (2024) Molecular Pathway, Epidemiological Data and Treatment Strategies of
Fungal Infection (Mycoses): A Comprehensive Review. Central Nervous System Agents in Medicinal Chemistry 24:1, pages 68-81.
Crossref
Crossref
K. P. Sreelakshmi, M. Madhuri, R. Swetha, Vivek Rangarajan & Utpal Roy. (2024) Microbial lipopeptides: their pharmaceutical and biotechnological potential, applications, and way forward. World Journal of Microbiology and Biotechnology 40:4.
Crossref
Crossref
Emily Puumala, Sara Fallah, Nicole Robbins & Leah E. Cowen. (2024) Advancements and challenges in antifungal therapeutic development. Clinical Microbiology Reviews 37:1.
Crossref
Crossref
Hamza Ettadili & Caner Vural. (2024) Current global status of Candida auris an emerging multidrug-resistant fungal pathogen: bibliometric analysis and network visualization. Brazilian Journal of Microbiology 55:1, pages 391-402.
Crossref
Crossref
Grecia Figueroa-Ramos, Samantha Paola Bermúdez-Rodríguez, Michelle Gatica-Torres, Alejandro Barrera-Godínez, Alexandro Bonifaz & Judith Domínguez-Cherit. (2024) Non-superficial Cutaneous Manifestations by Candida Species. Current Fungal Infection Reports 18:1, pages 51-59.
Crossref
Crossref
Ali Ahmadi, Bahareh Bashardoust, Mahsa Abdorahimi, Selva Aminizadeh, Mohammadreza Salehi & Sadegh Khodavaisy. (2023) Emerging Challenges in Diagnosis and Treatment of Invasive Fungal Infections: Addressing the Impact of COVID-19 and New Pathogens. Current Fungal Infection Reports 17:4, pages 296-308.
Crossref
Crossref
Emmanuel Novy, Claire Roger, Jason A. Roberts & Menino Osbert Cotta. (2023) Pharmacokinetic and pharmacodynamic considerations for antifungal therapy optimisation in the treatment of intra-abdominal candidiasis. Critical Care 27:1.
Crossref
Crossref
Matteo Guarino, Benedetta Perna, Alice Eleonora Cesaro, Martina Maritati, Michele Domenico Spampinato, Carlo Contini & Roberto De Giorgio. (2023) 2023 Update on Sepsis and Septic Shock in Adult Patients: Management in the Emergency Department. Journal of Clinical Medicine 12:9, pages 3188.
Crossref
Crossref
Antonio Vitiello, Francesco Ferrara, Mariarosaria Boccellino, Annarita Ponzo, Carla Cimmino, Emilio Comberiati, Andrea Zovi, Salvatore Clemente & Michela Sabbatucci. (2023) Antifungal Drug Resistance: An Emergent Health Threat. Biomedicines 11:4, pages 1063.
Crossref
Crossref
Renátó Kovács & Shahram Mahmoudi. (2023) Editorial: Alternative approaches to antifungal drugs against drug-resistant fungi. Frontiers in Cellular and Infection Microbiology 13.
Crossref
Crossref